secwatch.observer — SEC 8-K summary
======================================

Issuer:     Singular Genomics Systems, Inc. (—)
CIK:        0001850906
Form:       8-K
Filed at:   2025-02-27T23:59:59+00:00
Accession:  0001193125-25-038756
Event type: m_and_a
Sentiment:  neutral
Materiality: 0.90
Item codes: 1.01, 2.01, 2.03, 3.01, 3.03, 5.01, 5.02, 5.03, 8.01, 9.01
LLM model:  deepseek-v4-flash:cloud@v2

Singular Genomics acquired by Deerfield for $20/share; becomes private company
------------------------------------------------------------------------------

- Merger closed Feb 21, 2025; stockholders received $20.00 per share in cash.
- Total cash consideration of approx $37M for outstanding shares not rolled over.
- Stock delisted from Nasdaq; trading suspended effective Feb 21, 2025.
- Josh Stahl appointed CEO; Drew Spaventa continues as Board member and special advisor.
- Deerfield provided $37.5M term loan at 8% due Feb 20, 2026 to fund acquisition.

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/1850906/000119312525038756/0001193125-25-038756-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/1850906/000119312525038756/d923657d8k.htm
  HTML page:      https://secwatch.observer/filing/0001193125-25-038756

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer